Recently published papers: changing practices in the modern intensive care unit by Forni, Lui G
111 ARDS = acute respiratory distress syndrome; ICU = intensive care unit; PAOP = pulmonary artery occlusion pressure.
Available online http://ccforum.com/content/7/2/111
‘By far the best proof is experience.’
Sir Francis Bacon, 1561–1626
One always reviews the journals in January with some
trepidation. Wading through the instructions for authors (a
problem not encountered with the electronic press!), one is
worried that the scientific literature may need resuscitating
from the post-holiday somnolence. Fortunately, 2003 has
been greeted with a fanfare of important papers in the critical
care press, not least in the shape of some well conducted
observational studies. Those involved in the intensive care
arena often find themselves making difficult decisions,
including that of cessation of therapy or, indeed, whether to
admit a particular patient to the intensive care unit (ICU). The
latter dilemma often causes much debate between clinicians.
Two studies were published in Critical Care Medicine that
may help in determining patient selection.
The study by Benoit and coworkers [1] attempted to assess
outcome and early prognostic indicators in a global population
of patients with haematological malignancies following
admission to intensive care. This is a group of patients in which
resistance among intensivists to admission is often
encountered, despite the undoubted improvements in treatment
of both solid tumours and haematological malignancies. This
study from Belgium examined 124 consecutive critically ill
patients admitted to the ICU over a 3.5-year period. The overall
ICU mortality rate was 42%. The in-hospital mortality rate was
54% and the 6-month mortality rate was 66%. This somewhat
flies in the face of other studies, which have suggested mortality
rates of 75–85% in patients with haematological malignancies
who require mechanical ventilation.
The usual statistical models of multivariable logistic
regression analysis were applied to the data and four
variables were independently associated with outcome. It is
worth noting that no patient with oliguria survived, but oliguria
was not included in the multivariable analysis. Leukopenia,
use of vasopressors and an elevated urea were
independently associated with an increased risk for death.
Interestingly, proven bacteraemia was associated with a
lower risk. This latter finding was teased apart in more detail
but the analysis was somewhat limited by the number of
patients, although it appears that there is some correlation,
with Gram-positive bacteraemia having a slightly lower
mortality rate. Of note, only patients with potential long-term
survival or with a treatable relapse were admitted, and the
fact that the average Acute Physiology and Chronic Health
Evaluation II score was 26 suggests that this was a
dependant group.
Perhaps the most useful aspect of this paper is not in
highlighting that such patients may survive life-threatening
complications but rather in helping to indicate which patients
will do particularly badly. No patient with an elevated urea,
leukopenia and vasopressor requirement survived at
6 months. Such predictive data aid clinical judgement with
regard to escalation of therapy, and this may prove useful.
What is clear from the study is that the attitudes of
intensivists toward active management of such conditions
appears to be changing from that of the late 1980s [2].
In the same issue of Critical Care Medicine, a study
conducted by Tanvetyanon and Leighton [3] examined the
use of life-sustaining treatments in patients who died in
chronic congestive heart failure as compared with in those
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who died of metastatic cancer. This was a retrospective
medical record review and highlighted quite clearly that
patients who died of chronic refractory congestive heart
failure received significantly more intensive treatment than did
patients with metastatic cancer. What was interesting is that
the primary care physicians for many of the patients with
congestive heart failure noted the expected poor prognosis in
the admission notes. Despite this, many then went on to
receive full life support and spent time in the coronary care
unit. Although end-of-life decisions are often discussed in
patients with terminal malignancy, this does not appear to be
applied quite so enthusiastically to those with severe
congestive heart failure. Hopefully, as more knowledge with
regard to end-of-life care becomes both more available and
acceptable, perhaps those who die from congestive heart
failure may not have to suffer more than those with cancer.
Perhaps the study that will attract most attention is that by
Sandham and coworkers [4]. This is an impressive randomized
trial that compared goal-directed therapy guided by pulmonary
artery catheter with standard care without such intervention.
Almost 2000 patients underwent randomization over a period
between March 1990 and July 1999. Baseline variables
between the two treatment groups were similar and the
patients were all aged over 60 years and were at least
American Society of Anesthesiologists class III. The
conclusions were that there was no benefit to therapy directed
by pulmonary artery catheters over standard care in this patient
group. Indeed, there was a higher rate of pulmonary embolism
in the catheter group than in the standard treatment arm. The
physiological goals and treatment priorities in the pulmonary
artery catheter group were defined by the investigators before
the study began, and assessment of achievement of these
goals was based on the highest value obtained; however, it
does not appear that preoperative optimisation was achieved.
No such treatment aims in the standard catheter group were
specified, although interestingly the reported central venous
pressures for both groups did not differ significantly but both
were increased from preoperative values, suggesting that in
the control group significant ‘goal-directed’ therapy was
employed. No conclusions can be made that goal-directed
therapy is not beneficial to high-risk surgical patients given that
in this trial it would be expected that clinicians would deliver
appropraite fluid therapy governed by changes in the central
venous pressure, as well as other parameters indicative of
circulatory changes. Indeed, no data is presented with regard
to total volumes infused, although the treatment arm did
receive slightly more colloid than packed red cells. Also slightly
worrisome is that the overall numbers collected were not great
given the ten year period of study, which may reflect changes
in practice or indeed the exclusion of those patients who
would be expected to benefit most, such as the sickest
surgical patients.
This is an important study in the context of elderly high-risk
surgical patients, but whether goal-directed therapy should
be applied to other groups is a different matter. Many ICUs
still employ the use of a pulmonary artery catheter in patients
with acute lung injury and/or circulatory and/or septic shock.
It is perhaps in this group that more trials should be
conducted, at a time when other technologies such as the
oesophageal Doppler are being adopted with the same
enthusiasm as that of the balloon directed pulmonary artery
catheter in the early 1980s. There is some good news for the
pulmonary artery catheter enthusiasts – there was no excess
mortality in the treatment arm!
A report in Critical Care Medicine carries an interesting
hypothesis based on the application of an artificial neural
network to estimate pulmonary artery occlusion pressure
(PAOP) from the pulsatile pulmonary artery waveform [5].
Personally, I found this particularly intriguing. Many of us use
the pulmonary artery catheter as a surrogate for left atrial filling
pressures in our day-to-day ICU practice, but we all
acknowledge that obtaining this requires time, effort and some
skill, as well as involving some risk to the patient. The fact that
this technique is so operator dependant can occasionally lead
to misinterpretation of data. The study involved catheterization
of the right external jugular vein in dogs and assessment of
the pulmonary artery waveforms via digital sampling. The
neural network was ‘trained’ on 80% of the sample and then
tested on the remaining 20%. It appears that this neural
network could accurately estimate PAOP and could provide
accurate real-time estimates of PAOP in critically ill patients.
With luck, in the future neural networks may provide the
answer to the European time working directive.
The initial papers discussed here dealt with patients that
intensivists until recently have tried to avoid. However, the
acute respiratory distress syndrome (ARDS) continues to be
much loved, providing challenges in treatment and much
discussion. ARDS continues to occupy much of health care
resources, but little is known regarding the long-term
outcome of survivors. The paper by Herridge and coworkers
[6] must be applauded on several counts. A total of 109
survivors of ARDS were evaluated at 3, 6 and 12 months
after discharge. Patients were interviewed at these times as
well as undergoing a physical examination, pulmonary
function testing, a 6-min walk test and quality of life
evaluation. One of the most impressive feats for those of us
who live and work on this small island is that, when follow-up
appointments were missed, the patient was given the
opportunity to reschedule or request a home visit. The home
visits were limited to a round trip travel time of 10 hours from
the Greater Toronto area (approximately 700 km). The
tenacity of the investigators cannot be underestimated – their
enthusiasm is almost the equivalent of me performing a
domicillary visit in Manchester!
The study had a 36-month recruitment period and 198 of
228 eligible patients were recruited, of whom 117 survived.
The major differences between surviving patients and those113
who succumbed was that the survivors were in the main
younger, had a lower Acute Physiology and Chronic Health
Evaluation II score (23 versus 28), lower maximal lung injury
score, lower rates of sepsis, and a higher rate of trauma-
related ARDS. Also, those who survived had a lower
requirement for renal replacement therapy. In terms of follow
up, one may expect that limitations to daily activity would be
associated with pulmonary compromise, but this was not the
case. By 6 months after admission lung volumes were
normal, although diffusion capacity did remain low throughout
the 12-month follow-up period. The patients stated that
functional limitation was due to muscle weakness and
fatigue. The results implied that the inability to exercise was
primarily due to extrapulmonary complications rather than
pulmonary ones. The report is particularly convincing in that
all patients reported some degree of fatigue and muscle
weakness and, although 6-min walk times did improve after
12 months, the median was still only 66% of that predicted.
Questions then arise as to whether such problems are a
sequela of ARDS, but this seems highly unlikely. It would be
difficult to hypothesize that such problems would not affect
those with other critical illnesses, given that ARDS is not so
much a disease but a consequence of severe injury. What
the study does highlight is the fact that our knowledge of
critical illness polyneuropathy and myopathy is scant. The
challenge now is to try to identify risk factors for such
debilitating sequelae as well as to include such problems as
outcome measures in trials on ICU survival.
Napoleon Bonaparte was no great lover of physicians:
‘[Medicine is] a collection of uncertain prescriptions the
results of which, taken collectively, are more fatal than useful
to mankind.’ Let us hope that this is not the case in our long-
stay patients!
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